The murine version of BAN2401 (mAb158) selectively reduces amyloid-beta protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice

Manuscript Number: 

14-0741R2

Author(s): 
Par Gellerfors, Lars Lannfelt, Hanna Laudon, Anna Lord, Christer Moller, Gunilla Osswal, Charlotte Sahlin, Andrew Satlin, Johan Sjodahl, Linda Soderberg, Erika Spens, Karin Tegerstedt, Stina Tucker, Erik Rollman Waar

Disclosures

Par Gellerfors

  • Sponsors:
    BioArctic Neuroscience AB
    Patents/Royalties
    WO 2005/123775 A1 WO 2005/089539 A1 WO 2007/108756 A1

Lars Lannfelt

  • Equity:
    Owner of stocks in BioArctic Neuroscience AB
    Sponsors:
    Partly employed by BioArctic Neuroscience AB
    Patents/Royalties
    Patents around the treatment concept for BioArctic Neuroscience AB

Hanna Laudon

  • Sponsors:
    Employed by BioArctic Neuroscience.

Anna Lord

  • Equity:
    Stockholder, BioArctic Neuroscience AB

Christer Moller

  • Sponsors:
    BioArctic Neuroscience AB

Gunilla Osswal

  • Sponsors:
    BioArctic Neuroscience AB

Charlotte Sahlin

  • Sponsors:
    Employed by BioArctic Neuroscience

Andrew Satlin

  • Sponsors:
    Eisai, Inc.

Johan Sjodahl

  • Sponsors:
    BioArctic Neuroscience AB

Linda Soderberg

  • Nothing to Disclose

Erika Spens

  • Sponsors:
    BioArctic Neuroscience

Karin Tegerstedt

  • Nothing to Disclose

Stina Tucker

  • Sponsors:
    Full-time employee of BioArctic Neuroscience

Erik Rollman Waar

  • Sponsors:
    I am employed by BioArctic Neuroscience AB